These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 9266239)

  • 1. Relationship between DNA ploidy and functional estrogen receptors in operable prostate cancer.
    Nativ O; Umehara T; Colvard DS; Therneau TM; Farrow GM; Spelsberg TC; Lieber MM
    Eur Urol; 1997; 32(1):96-9. PubMed ID: 9266239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A DNA cytometric proliferation index improves the value of the DNA ploidy pattern as a prognosticating tool in patients with carcinoma of the prostate.
    Ahlgren G; Lindholm K; Falkmer U; Abrahamsson PA
    Urology; 1997 Sep; 50(3):379-84. PubMed ID: 9301701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA ploidy and proliferation heterogeneity in human prostate cancers.
    Shankey TV; Jin JK; Dougherty S; Flanigan RC; Graham S; Pyle JM
    Cytometry; 1995 Sep; 21(1):30-9. PubMed ID: 8529468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of steroid hormone receptor content and flow cytometric DNA ploidy in endometrial carcinoma.
    Grénman SE; Klemi P; Toikkanen S; Irjala K; Laippala P; Vähä-Eskeli K; Mäenpää J; Salmi T
    Ann Chir Gynaecol Suppl; 1994; 208():10-4. PubMed ID: 8092757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between DNA ploidy, glandular differentiation, and tumor spread in human prostate cancer.
    Frankfurt OS; Chin JL; Englander LS; Greco WR; Pontes JE; Rustum YM
    Cancer Res; 1985 Mar; 45(3):1418-23. PubMed ID: 3971384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flow cytometric determination of ploidy in prostatic adenocarcinoma and its relation to clinical outcome.
    Blatstein LM; Ginsberg PC; Daskal I; Finkelstein LH
    J Am Osteopath Assoc; 1993 Apr; 93(4):463-8, 471-2. PubMed ID: 8478220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of DNA ploidy, bcl-2 and p53 in localized prostate adenocarcinoma incidentally discovered at transurethral prostatectomy.
    Abaza R; Diaz LK; Laskin WB; Pins MR
    J Urol; 2006 Dec; 176(6 Pt 1):2701-5. PubMed ID: 17085199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deoxyribonucleic acid ploidy status as no basis for pathologic stage prediction in clinically resectable prostate cancer.
    Egawa S; Satoh T; Iwamura M; Aihara M; Kuwao S; Uchida T; Koshiba K
    Urology; 1996 Apr; 47(4):548-52. PubMed ID: 8638366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of tamoxifen on steroid hormone receptors and hormone concentration and the results of DNA analysis by flow cytometry in endometrial carcinoma.
    Nola M; Jukić S; Ilić-Forko J; Babić D; Uzarević B; Petrovecki M; Suchanek E; Skrablin S; Dotlić S; Marusić M
    Gynecol Oncol; 1999 Mar; 72(3):331-6. PubMed ID: 10053103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deoxyribonucleic acid ploidy and serum prostate specific antigen predict outcome following salvage prostatectomy for radiation refractory prostate cancer.
    Amling CL; Lerner SE; Martin SK; Slezak JM; Blute ML; Zincke H
    J Urol; 1999 Mar; 161(3):857-62; discussion 862-3. PubMed ID: 10022701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of DNA ploidy analysis in endometrial adenocarcinoma.
    Jhala DN; Atkinson BF; Balsara GR; Hernandez E; Jhala NC
    Ann Diagn Pathol; 2001 Oct; 5(5):267-73. PubMed ID: 11598854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between nuclear DNA distribution and estrogen receptors in human mammary carcinomas.
    Auer GU; Caspersson TO; Gustafsson SA; Humla SA; Ljung BM; Nordenskjöld BA; Silfverswärd C; Wallgren AS
    Anal Quant Cytol; 1980 Dec; 2(4):280-4. PubMed ID: 7469203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ploidy, proliferative activity and estrogen receptor content in human breast cancer.
    Raber MN; Barlogie B; Latreille J; Bedrossian C; Fritsche H; Blumenschein G
    Cytometry; 1982 Jul; 3(1):36-41. PubMed ID: 7117052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Steroid hormone receptors and flow cytometric DNA ploidy in ovarian carcinoma.
    Grénman SE; Klemi P; Toikkanen S; Kaihola HL; Laippala P; Mäenpää J; Mäkinen J; Grönroos M
    Ann Chir Gynaecol Suppl; 1994; 208():15-9. PubMed ID: 8092763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Smad4 protein expression correlates with grade, stage, and DNA ploidy in prostatic adenocarcinomas.
    Sheehan GM; Kallakury BV; Sheehan CE; Fisher HA; Kaufman RP; Ross JS
    Hum Pathol; 2005 Nov; 36(11):1204-9. PubMed ID: 16260274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stage C prostatic adenocarcinoma: flow cytometric nuclear DNA ploidy analysis.
    Nativ O; Winkler HZ; Raz Y; Therneau TM; Farrow GM; Myers RP; Zincke H; Lieber MM
    Mayo Clin Proc; 1989 Aug; 64(8):911-9. PubMed ID: 2796401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Near-diploidy: a new prognostic factor for clinically localized prostate cancer treated with external beam radiation therapy.
    Pollack A; Zagars GK; el-Naggar AK; Gauwitz MD; Terry NH
    Cancer; 1994 Apr; 73(7):1895-903. PubMed ID: 7511039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Near tetraploid prostate carcinoma. Methodologic and prognostic aspects.
    Forsslund G; Nilsson B; Zetterberg A
    Cancer; 1996 Oct; 78(8):1748-55. PubMed ID: 8859188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical utility of cellular DNA measurements in prostate carcinoma. Consensus Conference on Diagnosis and Prognostic Parameters in Localized Prostate Cancer. Stockholm, Sweden, May 12-13, 1993.
    Schröder F; Tribukait B; Böcking A; DeVere White R; Koss L; Lieber M; Stenkvist B; Zetterberg A
    Scand J Urol Nephrol Suppl; 1994; 162():51-63; discussion 15-27. PubMed ID: 7529429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The significance of tumor heterogeneity for prediction of DNA ploidy of prostate cancer.
    Häggarth L; Auer G; Busch C; Norberg M; Häggman M; Egevad L
    Scand J Urol Nephrol; 2005; 39(5):387-92. PubMed ID: 16257840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.